These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models. Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923 [TBL] [Abstract][Full Text] [Related]
3. Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi. Diniz Lde F; Caldas IS; Guedes PM; Crepalde G; de Lana M; Carneiro CM; Talvani A; Urbina JA; Bahia MT Antimicrob Agents Chemother; 2010 Jul; 54(7):2979-86. PubMed ID: 20404124 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Urbina JA; Payares G; Sanoja C; Lira R; Romanha AJ Int J Antimicrob Agents; 2003 Jan; 21(1):27-38. PubMed ID: 12507835 [TBL] [Abstract][Full Text] [Related]
5. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice. Diniz LF; Mazzeti AL; Caldas IS; Ribeiro I; Bahia MT Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555633 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach. Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395 [TBL] [Abstract][Full Text] [Related]
9. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease. Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982 [TBL] [Abstract][Full Text] [Related]
11. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives. Urbina JA J Eukaryot Microbiol; 2015; 62(1):149-56. PubMed ID: 25284065 [TBL] [Abstract][Full Text] [Related]
12. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase. Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582 [TBL] [Abstract][Full Text] [Related]
13. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model. Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170 [TBL] [Abstract][Full Text] [Related]
14. Enzymatic synthesis of amlodipine amides and evaluation of their anti- Elso OG; Bivona AE; Cenizo R; Malchiodi EL; García Liñares G Org Biomol Chem; 2023 Feb; 21(7):1411-1421. PubMed ID: 36722938 [TBL] [Abstract][Full Text] [Related]
16. Ravuconazole self-emulsifying delivery system: in vitro activity against Spósito PÁ; Mazzeti AL; de Oliveira Faria C; Urbina JA; Pound-Lana G; Bahia MT; Mosqueira VF Int J Nanomedicine; 2017; 12():3785-3799. PubMed ID: 28553114 [TBL] [Abstract][Full Text] [Related]
17. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii. Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064 [TBL] [Abstract][Full Text] [Related]
18. A functional assay using human whole blood and flow cytometry analysis to evaluate cytotoxicity and immunomodulatory effect of anti-Trypanosoma cruzi drugs. Lopes MEASA; Ribeiro JM; Teixeira-Carvalho A; Murta SMF; Souza-Fagundes EM Exp Parasitol; 2023 Apr; 247():108490. PubMed ID: 36809831 [TBL] [Abstract][Full Text] [Related]
19. 4-nitrobenzoylcoumarin potentiates the antiparasitic, anti-inflammatory and cardioprotective effects of benznidazole in a murine model of acute Trypanosoma cruzi infection. Vilas-Boas DF; Oliveira RRG; Gonçalves-Santos E; Silva LS; Diniz LF; Mazzeti AL; Brancaglion GA; Carvalho DT; Caldas S; Novaes RD; Caldas IS Acta Trop; 2022 Apr; 228():106314. PubMed ID: 35038424 [TBL] [Abstract][Full Text] [Related]
20. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II). Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]